Zolbetuximab plus mFOLFOX6 successful in CLDN18.2-positive subgroup of gastric cancer Presented ByDr Kohei Shitara, National Cancer Center Hospital East, Japan TrialPhase 3, SPOTLIGHT ConferenceASCO GI 2023 17 March, 2023 08:31